University Hospital, Akershus

This phase 2 trial is testing whether adding the immunotherapy drug nivolumab (Opdivo) to standard chemotherapy (oxaliplatin, 5-fluorouracil, folinic acid) can help control or shrink a hard-to-treat type of metastatic colorectal cancer (pMMR/MSS). The study includes 80 adults who…

This study looks at whether certain blood markers can identify people without significant coronary artery disease, avoiding the need for more invasive tests. Researchers will enroll 1000 adults referred for a CT scan of the heart. The goal is to see if these biomarkers can accura…

This study looks at whether giving infliximab over 30 minutes is as safe as the standard 60-minute infusion for children with inflammatory bowel disease (IBD). About 60 kids aged 1-17 who have already had at least 5 infusions will receive 8 infusions, alternating between the two …

This study looks at whether giving doctors early results from heart biomarker tests (NT-proBNP and hs-cTnT) along with a structured interpretation note can improve outcomes for patients admitted with rapid breathing (tachypnea). About 574 adults will be randomly assigned to recei…

This study follows 1,400 women who had a stroke with no known cause. Researchers use an implantable heart monitor to check for hidden atrial fibrillation (an irregular heartbeat) and see if blood thinners can reduce the risk of another stroke. The goal is to understand if women b…

This study follows 450 people with gender incongruence who are starting or continuing gender-affirming hormone therapy. Researchers will use heart scans, blood tests, and quality-of-life surveys over time to see if the therapy has negative, neutral, or positive effects on the hea…